Lyme Wellness Initiative Advisory Panel
Advisory panel biographies for the Lyme Wellness Initiative.
Donna Felsenstein, MD
Donna Felsenstein, MD is an Infectious Disease Specialist at Massachusetts General Hospital (MGH) in Boston, MA. A graduate of Harvard Medical School, she completed her residency training and Infectious Disease Fellowship at MGH in 1985, joining the Attending Staff of the Infectious Disease Unit at MGH at that time. Dr. Felsenstein developed the Outpatient Infectious Disease practice at the hospital.She was the Medical Director of the Sexually Transmitted Disease (STD) Unit for its first 30 years. Her experience with and insight into the neurologic manifestations of syphilis fostered her interest in those of Lyme disease. In addition, for the past 40 years Dr. Felsenstein has evaluated and treated patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Richard Horowitz, MD
Richard Horowitz, MD is a board-certified internist and medical director of the Hudson Valley Healing Arts Center, specializing in the treatment of tick-borne disorders. He has treated over 13,000 chronic Lyme disease patients in the past 30 years and is a prior member of the HHS Tick-borne Disease Working Group (TBDWG) and Co-chair of the HHS Other Tick-borne Diseases and Co-infection subcommittee. He is presently a member of the NYS DOH TBDWG. His latest book “How Can I Get Better? An Action Plan for Treating Resistant Lyme and Chronic Disease” explains his comprehensive approach to treating resistant chronic illness.
Anthony L. Komaroff, MD
Anthony L. Komaroff, MD is the Simcox/Clifford/Higby Distinguished Professor of Medicine at Harvard Medical School and a Senior Physician at Brigham & Women's Hospital. He has served as Director of the Division of General Medicine at Brigham & Women's Hospital; Editor-in-Chief of the Harvard Health Publications Division of Harvard Medical School; and Founding Editor of NEJM Journal Watch General Medicine. He is a clinician, teacher, and research scientist who has published over 270 research articles on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID, illnesses similar to what sometimes occurs following Lyme disease. He also studies human herpesviruses 6A and 6B.
Elizabeth Lee Lewandrowski, PhD, MPH
Elizabeth Lee Lewandrowski, PhD, MPH is on the faculty of the Department of Pathology at the Massachusetts General Hospital in Boston, Massachusetts and serves as a Clinical Laboratory Scientist in Chemistry. She is an Assistant Professor of Pathology at Harvard Medical School. Dr Lee-Lewandrowski received her Ph.D. in Chemistry from Brown University and her MPH from the Harvard School of Public health. She joined the staff of the Massachusetts General Hospital in 1999. Her research interests are focused on the clinical applications of point-of-care testing technologies to improve outcomes and the efficiency of clinical operations. Dr. Lee-Lewandrowski has recently been conducting research and directing continuing education conferences on Lyme disease and other tick-borne infections.
Peter Novak, MD, PhD
Peter Novak, MD, PhD is the Director of the Autonomic Laboratory at Brigham and Women’s Hospital. He is a board-certified neurologist and a board-certified autonomic specialist. He is a member of the American Academy of Neurology, the American Autonomic Society, and the Autonomic Board of United Council for Neurologic Subspecialties (UCNS). He graduated from medical school in Bratislava, Slovakia and completed his neurology residency at the Ohio State University. He also completed postdoctoral studies focusing on cardiovascular and autonomic research at Charles University (Prague), University of Montreal, McGill University (Montreal) and Mayo Clinic. He has special interests in autoimmune, small fiber, and autonomic neuropathies associated with COVID-19 and Lyme disease, postural tachycardia syndrome (POTS), and multiple system atrophy. He has written over 80 papers and presented at numerous conferences.
Nancy Shadick, MD
NancyShadick, MD is a Rheumatologist, Associate Professor of Medicine at Harvard Medical School. She is an experienced clinical researcher in health outcomes, epidemiology, and Lyme disease. She has directed and funded numerous population and clinic-based studies and maintained several cohort studies, including the Nantucket Island Lyme Disease Cohort Study and the BRASS RA Registry and the COPPAR Psoriasis and Psoriatic Arthritis Cohort. She is a recipient of Arthritis Foundation, NIH, CDC and Industry grants and serves on several advisory boards and grant review committees related to rheumatoid arthritis and Lyme disease and has published numerous studies on this topic.
Daniel A. Solomon, MD
Daniel A. Solomon, MD is a clinician educator in the Division of Infectious Diseases at Brigham and Women’s Hospital. His clinical interests are in caring for patients with HIV, Hepatitis C, and tickborne diseases and he has specific expertise in the management of infections related to injection drug use. He is an Assistant Professor of Medicine at Harvard Medical School where he is the Morgan-Zinsser Associate Director of Clinical Learning in the Health Sciences and Technology (HST) track.